Gossamer Bio (GOSS) EBITDA (2018 - 2026)
Gossamer Bio (GOSS) posted EBITDA of -$44.86 million for Q1 2026, compared with -$36.8 million a year earlier.
Powered by 
Analysis
Gossamer Bio (GOSS) EBITDA (2018 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, EBITDA at Gossamer Bio was -$178.76 million; for FY2025, it was -$170.7 million.
- In prior years, Gossamer Bio's EBITDA was -$59.09 million in FY2024, -$182.15 million in FY2023, -$216.76 million in FY2022 and -$214.38 million in FY2021.
- Quarterly EBITDA has run from a low of -$55.52 million in Q3 2022 to a high of $52.39 million in Q2 2024 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$46.03 million (Q4 2025), -$49.11 million (Q3 2025) and -$38.76 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Gossamer Bio | 37.88 Mn | -435.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -44.61 Mn |
| Dec 31, 2025 | -45.78 Mn |
| Sep 30, 2025 | -48.86 Mn |
| Jun 30, 2025 | -38.51 Mn |
| Mar 31, 2025 | -36.56 Mn |
| Dec 31, 2024 | -35.78 Mn |
| Sep 30, 2024 | -33.49 Mn |
| Jun 30, 2024 | 52.71 Mn |
| Mar 31, 2024 | -41.41 Mn |
| Dec 31, 2023 | -48.43 Mn |
| Sep 30, 2023 | -39.77 Mn |
| Jun 30, 2023 | -45.46 Mn |
| Mar 31, 2023 | -47.09 Mn |
| Dec 31, 2022 | -53.66 Mn |
| Sep 30, 2022 | -55.22 Mn |
| Jun 30, 2022 | -53.07 Mn |
| Mar 31, 2022 | -53.55 Mn |
| Dec 31, 2021 | -49.47 Mn |
| Sep 30, 2021 | -53.47 Mn |
| Jun 30, 2021 | -53.52 Mn |
API Access
Gossamer Bio EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=GOSS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "GOSS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=GOSS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();